Eli Lilly & Co. (LLY)

1058.15 +48.63 (+4.82%) USD  |  NYSE  |  Feb 23, 16:00
1056.70 -1.45 (-0.14%) After-Hours: 16:31
More

Eli Lilly Change in Payables and Accrued Expense (Quarterly)

Change in Payables and Accrued Expense (Quarterly) Chart

View Change in Payables and Accrued Expense (Quarterly) for LLY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Change in Payables and Accrued Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Change in Payables and Accrued Expense (Quarterly) Range, Past 5 Years

View Change in Payables and Accrued Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Change in Payables and Accrued Expense (Quarterly) Benchmarks

View Change in Payables and Accrued Expense (Quarterly) Benchmarks
Start Trial
Amgen, Inc. Upgrade
Biogen, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade
Viking Therapeutics, Inc. Upgrade
Moderna, Inc. Upgrade